ALS and fertility: does ALS affect number of children patients have?

被引:1
|
作者
Uysal, Hilmi [1 ]
Bilge, Ugur [2 ]
Ilhanli, Nevruz [2 ]
Gromicho, Marta [3 ]
Grosskreutz, Julian [4 ]
Kuzma-Kozakiewicz, Magdalena [5 ,6 ,7 ]
Pinto, Susana [3 ]
Petri, Susanne [8 ]
Szacka, Katarzyna [7 ]
Nieporecki, Krzysztof [7 ]
De Carvalho, Mamede [3 ,9 ]
机构
[1] Akdeniz Univ, Dept Neurol & Clin Neurophysiol, Fac Med, Antalya, Turkey
[2] Akdeniz Univ, Dept Biostat & Med Informat, Fac Med, Antalya, Turkey
[3] Univ Lisbon, Fac Med, Inst Physiol, Inst Med Mol, Lisbon, Portugal
[4] Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Germany
[5] Med Univ Warsaw, Dept Neurol, Warsaw, Poland
[6] Med Univ Warsaw, Neurodegenerat Dis Res Grp, Warsaw, Poland
[7] Med Univ Warsaw, Univ Clin Ctr, Dept Neurol, Warsaw, Poland
[8] Hannover Med Sch, Dept Neurol, Hannover, Germany
[9] Ctr Hosp Univ Lisboa Norte, Dept Neurosci & Mental Hlth, Lisbon, Portugal
关键词
Amyotrophic lateral sclerosis; number of offspring; fertility; selection pressure; AMYOTROPHIC-LATERAL-SCLEROSIS; DISEASE;
D O I
10.1080/21678421.2020.1813313
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective Amyotrophic Lateral Sclerosis is one major disease in the group of neurodegenerative conditions. As with most other neurodegenerative diseases, clinical signs of the disease usually show among the elderly population, and most commonly around 60-65 years of age. Therefore the disease is not expected to impact the fertility of ALS patients. When examined from an evolutionary medicine and evolutionary biology perspective, there should be no selection pressure on the patient population due to the late onset of ALS.Methods: In this study, we tested the hypothesis that ALS does not affect fertility on a group of patients with ALS that we collected in a multi-center study. We recruited 511 patients diagnosed with ALS according to the revised El Escorial criteria, and 236 control cases without a neurodegenerative disease. We compared the ALS group's number of offspring with the control group in three consecutive generations.Results: No statistically significant difference was found between the number of siblings of ALS and control groups (p = 0.44). A statistically significant difference was found between the number of children of ALS and control groups (p < 0.001), indicating ALS patients had more children than controls. When the number of children is assessed by gender, for women, there was no statistically significant difference between the number of children of ALS and control groups (p = 0.067).Conclusions: This finding supports the view that ALS does not have a negative selection pressure on the patient population's fertility.
引用
下载
收藏
页码:94 / 100
页数:7
相关论文
共 50 条
  • [31] IS IT ALS? CHALLENGING DIAGNOSES IN PATIENTS WITH MOTOR NEURON INVOLVEMENT MIMICKING ALS
    Fini, N.
    Plasmati, R.
    Pastorelli, F.
    Salvi, F.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S16 - S16
  • [32] Predicting dysphagia onset in patients with ALS: the ALS dysphagia risk score
    Perry, Bridget J.
    Nelson, J.
    Wong, J. B.
    Kent, D. M.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2022, 23 (3-4) : 271 - 278
  • [33] Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?
    Vaisman, Nachum
    Lusaus, Michal
    Nefussy, Beatrice
    Niv, Eva
    Comaneshter, Doron
    Hallack, Ron
    Drory, Vivian E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 279 (1-2) : 26 - 29
  • [34] Engaging ALS patients and caregivers (the ALS research ambassadors) to help design the REFINE-ALS biomarker study
    Berry, James D.
    Bedlack, Richard
    Mathews, Debra
    Agnese, Wendy
    Apple, Stephen
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2021, 22 (1-2) : 147 - 150
  • [35] Dextromethorphan-Quinidine (Nuedexta) Improves Swallowing in Bulbar Onset ALS Patients with Pseudobulbar Affect - Pre-Post Observational Study in 86 ALS Patients
    Shah, Nathasha Saurin
    Wright, Kathryn Amy
    Bravver, Elena K.
    Desai, Urvi G.
    Langford, Velma
    Bockenek, William L.
    Lindblom, Scott S.
    Linville, Any N.
    Paling, Fawn
    Williamson, Tiffany A.
    Brooks, Benjamin Rix
    NEUROLOGY, 2019, 92 (15)
  • [36] 40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?
    Ng Kee Kwong, Koy Chong
    Harbham, Pratap K.
    Selvaraj, Bhuvaneish T.
    Gregory, Jenna M.
    Pal, Suvankar
    Hardingham, Giles E.
    Chandran, Siddharthan
    Mehta, Arpan R.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 14
  • [37] Kynurenic acid in ALS patients
    Iwasaki, Y
    Igarashi, O
    Ichikawa, Y
    Aoyagi, J
    Kawase, Y
    Kiyozuka, T
    Iguchi, H
    Kawabe, K
    Maruyama, M
    Ikeda, K
    Fujioka, T
    ACTA NEUROLOGICA SCANDINAVICA, 2004, 109 (03): : 236 - 236
  • [38] Parasympathetic dysfunction in ALS patients
    Lahrmann, H.
    Toeglhofer, E.
    Struhal, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 131 - 131
  • [39] Biological markers on patients with ALS
    Salevic-Obradovic, J.
    Arsic, D.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S311 - S312
  • [40] MRI biomarkers in ALS patients
    Merkul, V.
    Rushkevich, Y.
    Likhachev, S.
    Antonenko, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 633 - 633